JERE CLAUNCH: Open Payments
NPI 1518977867 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,984 in 88 payments from 21 companies in 2025. Trend: 2023 $2,881 · 2024 $3,247 · 2025 $1,984
Food & beverage: $1,984
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $549 |
| Axsome Therapeutics, Inc. | 17 | $370 |
| Bayer Healthcare Pharmaceuticals Inc. | 23 | $195 |
| Novo Nordisk Inc | 5 | $155 |
| OMNIlife science, Inc | 1 | $74 |
| Lundbeck LLC | 4 | $70 |
| Paratek Pharmaceuticals, Inc. | 4 | $65 |
| Esperion Therapeutics, Inc. | 3 | $61 |
| Corcept Therapeutics | 2 | $51 |
| Amgen Inc. | 3 | $48 |
Products named: Auvelity, FARXIGA, Kerendia, AIRSUPRA, Ozempic, BREZTRI, REXULTI, NUZYRA.
Industry payments across OK — which companies pay providers there.
